This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
e.l.f. Beauty (ELF) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), e.l.f. Beauty (ELF) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Markets Take a Powder; PLTR, NXPI Beat in Q4
by Mark Vickery
Market indices were reluctant to drag a stock market higher amid all-time high ranges on the Dow and S&P 500.
Estee Lauder (EL) Cuts FY24 Profit View Despite Q2 Earnings Beat
by Zacks Equity Research
Estee Lauder's (EL) second-quarter fiscal 2024 results reflect lower net sales and earnings amid global macroeconomic volatility. Management lowers fiscal 2024 earnings view.
E.l.f. Beauty (ELF) Stock Moves -0.92%: What You Should Know
by Zacks Equity Research
In the latest trading session, e.l.f. Beauty (ELF) closed at $159.53, marking a -0.92% move from the previous day.
These 3 Buy-Rated Stocks Are Red-Hot
by Derek Lewis
Relative strength investing is centered around targeting stocks displaying outperformance. And when you add in the Zacks Rank, the strategy becomes even more powerful.
Coty (COTY) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Coty (COTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Church & Dwight (CHD) Gears up for Q4 Earnings: What to Note?
by Zacks Equity Research
Church & Dwight (CHD) is likely to have seen growth in Q4 earnings, supported by strategic initiatives and consumer demand despite the potential impacts of increased expenses.
E.l.f. Beauty (ELF) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
E.l.f. Beauty (ELF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Beat the Market the Zacks Way: Rolls-Royce, Costco, e.l.f. Beauty in Focus
by Santanu Roy
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Colgate (CL) Q4 Earnings & Sales Beat Estimates, '24 View Issued
by Zacks Equity Research
Colgate's (CL) Q4 results benefited from strong sales growth, robust organic volume growth and gross and operating margin expansion.
Should iShares S&P Small-Cap 600 Growth ETF (IJT) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IJT
E.l.f. Beauty (ELF) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
E.l.f. Beauty (ELF) concluded the recent trading session at $156.55, signifying a +1.08% move from its prior day's close.
Is e.l.f. Beauty (ELF) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how e.l.f. Beauty (ELF) and Boston Beer (SAM) have performed compared to their sector so far this year.
Inter Parfums (IPAR) Q4 Sales Advance on Brand Strength
by Zacks Equity Research
Inter Parfums' (IPAR) U.S.-based operations witness remarkable 13% sales growth in the fourth quarter, primarily driven by Donna Karan/DKNY.
Is e.l.f. Beauty (ELF) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
e.l.f. Beauty (ELF) could produce exceptional returns because of its solid growth attributes.
E.l.f. Beauty (ELF) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
In the closing of the recent trading day, e.l.f. Beauty (ELF) stood at $157.79, denoting a +0.9% change from the preceding trading day.
Should Vanguard S&P Small-Cap 600 Growth ETF (VIOG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VIOG
Inter Parfums' (IPAR) Strategies Poise it for Growth in 2024
by Zacks Equity Research
Buoyed by robust momentum in the fragrance space and gains from product newness, Inter Parfums (IPAR) is set to witness another record year in 2024.
Should SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SLYG
Should SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPSM
Zacks.com featured highlights e.l.f. Beauty, Virco, Stride and Camtek
by Zacks Equity Research
e.l.f. Beauty, Virco, Stride and Camtek have been highlighted in this Screen of The Week article.
Is It Worth Investing in e.l.f. Beauty (ELF) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in e.l.f. Beauty (ELF). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
4 Solid Profitable Stocks to Buy Using Net Income Ratio
by Tirthankar Chakraborty
e.l.f. Beauty (ELF), Virco Manufacturing (VIRC), Stride (LRN), and Camtek (CAMT) have been selected as the top picks with a high net income ratio.
Pilgrim's Pride (PPC) Gains on Pricing, Operational Efficiency
by Zacks Equity Research
Pilgrim's Pride's (PPC) flexible pricing, customer-focused strategies and operational efficiency have been driving its strong performance and market adaptability across diverse regions.
Best Growth Stocks to Buy for January 15th
by Zacks Equity Research
DVA, AZZ and ELF made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 15, 2024.